In utero exposure to A-bomb radiation and mental retardation; a reassessment

The British Journal of Radiology
M Otake, W J Schull

Abstract

The prevalence of mental retardation in children exposed in utero to the atomic bombs in Hiroshima and Nagasaki has been re-evaluated in reference to gestational age and tissue dose in the fetus. There was no risk at 0-8 weeks post-conception. The highest risk of forebrain damage occurred at 8-15 weeks of gestational age, the time when the most rapid proliferation of neuronal elements and when most, if not all, neuroblast migration to the cerebral cortex from the proliferative zones is occurring. Overall, the risk is five or more times greater in these weeks than in subsequent ones. In the critical period, damage expressed as the frequency of subsequent mental retardation appears to be linearly related to the dose received by the fetus. A linear model is not equally applicable to radiation-related mental retardation after the 15th week, the observed values suggesting that there a threshold may exist. The data are consistent with a probability of occurrence of mental retardation of 0.40% per cGy or 40% per gray.

References

Dec 1, 1976·Teratology·R W Miller, J J Mulvihill
Oct 14, 1972·Lancet·R W Miller, W J Blot
Feb 1, 1973·Archives of Disease in Childhood·M A AshworthR D Milner
Sep 1, 1970·Archives of Environmental Health·R K Cannan
Apr 1, 1968·Journal of Neuropathology and Experimental Neurology·P Rakic, R L Sidman
Aug 1, 1967·American Journal of Public Health and the Nation's Health·J W WoodR J Keehn
Jul 1, 1982·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·R H Mole

❮ Previous
Next ❯

Citations

Jan 1, 1987·Annals of the ICRP
Jan 1, 1989·The British Journal of Radiology·J G Russell
Feb 1, 1986·The British Journal of Radiology·E W FletcherG Draper
Jan 1, 1986·The British Journal of Radiology·M J Day
Jan 1, 1986·The British Journal of Radiology·J G Russell
Jan 1, 1987·The British Journal of Radiology·E E Pochin
Nov 11, 1989·BMJ : British Medical Journal·R Pearson
Nov 1, 1987·Environmental Health Perspectives·D G Hoel
Jul 16, 1988·BMJ : British Medical Journal·E E Pochin
Oct 1, 1993·British Journal of Industrial Medicine·N RoeleveldF Gabreëls
Oct 1, 1995·Environmental Health Perspectives·E A KordyshR Gorodischer
Feb 21, 2004·AJR. American Journal of Roentgenology·Robert L Brent, Fred A Mettler
Sep 7, 2000·Neurotoxicology and Teratology·R Baskar, P U Devi
Oct 10, 1987·Lancet·R J Fry, W K Sinclair
Dec 31, 2002·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·J J NuyttensT E Williams
Oct 4, 2011·Pediatrics in Review·Robert L Brent
Dec 17, 2008·Pediatric Radiology·Eric J Hall
Nov 3, 2010·Developmental Neuropsychology·Kristin Sverdvik HeiervangBjørn Rishovd Rund
Nov 1, 1996·The International Journal of Neuroscience·N I BohnenL T Kurland
Jan 1, 1986·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·R H Mole
Aug 1, 1992·International Journal of Radiation Biology·Z J SienkiewiczB K Butland
Jul 6, 2013·The Orthopedic Clinics of North America·Louis F AmorosaDavid L Helfet
Jul 1, 1990·Journal of Neuroscience Research·G HamdorfA Skoberla
Jul 21, 2012·Cardiology Clinics·David L AinPartho P Sengupta
Nov 1, 1988·International Journal of Radiation Oncology, Biology, Physics·B F Kimler, S Norton
Mar 31, 2009·Journal of the Neurological Sciences·Michiko YamadaHideo Sasaki
Mar 10, 2016·Neurotoxicology·Dorothée C-M VercruysseFrederic Amant
Apr 7, 2007·Journal of the American College of Radiology : JACR·Jadwiga Jodi StrzelczykKatarzyna J Macura
Apr 9, 2008·Acta Paediatrica·Richard S Nowakowski, Nancy L Hayes
Jul 19, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Sarah Običan, Anthony R Scialli
Nov 1, 2011·Developmental Disabilities Research Reviews·Orna Diav-Citrin
Mar 29, 2014·Congenital Anomalies·Wladimir WerteleckiHolly H Hobart
Mar 27, 2010·Scandinavian Journal of Psychology·Kristin Sverdvik HeiervangBjørn Rishovd Rund
Jan 1, 1987·Reproductive Toxicology·A Lione
Oct 12, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Marco De SantisAlessandro Caruso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
A J WilcoxC R Weinberg
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Steve L HyerClive L Harmer
© 2021 Meta ULC. All rights reserved